IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Cancer Australia
Cancer Australia is a Government Body that generates the majority of its income from the Health Services industry. In 2023 the company generated total revenue of $13,547,000 including sales and other revenue. In 2023 Cancer Australia had 83 employees including employees from all subsidiaries under the company's control. The Chief Executive of Cancer Australia is Prof Dorothy Keefe whose official title is Chief Executive Officer. The Chairman of Cancer Australia is Associate Professor Chris Milross whose official title is Advisory Council Member (Chair). Cancer Australia is a Commonwealth government owned agency that is responsible for the national leadership of cancer control within Australia for those who are affected by cancer. The purpose of the agency is to lessen the impacts of cancer, address inequalities within cancer treatments, and the improvement of health outcomes in those with cancer. The functions of Cancer Australia are as follows: To offer national leadership regarding the control of cancer To manage the budget for research into cancer To make recommendations to the Australian Government about cancer policy and priorities To mentor scientific research to the prevention of cancer, care, and treatment, and to offer financial assistance for research To offer recommendations regarding the management of cancer to the Australian government and to offer assistance with the implementation of policy To liaise between the shareholders with an interest in the agency To organise and perform any function directed by the Minister
Access this data your way
The Cancer Australia Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Cancer Australia includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Cancer Australia, trading as Cancer Australia, operates under the ABN 21 075 951 918 and was incorporated on 01 June 2006. Cancer Australia primarily operates in the Health Services industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Cancer Australia, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Cancer Australia’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Cancer Australia operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Cancer Australia’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Industries of Operation
What’s included in the Industries of Operation chapter?
The Industries of Operation chapter outlines Cancer Australia’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Cancer Australia, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Cancer Australia. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Cancer Australia’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Cancer Australia?
Cancer Australia is a Commonwealth government owned agency that is responsible for the national leadership of cancer control within Australia for those who are affected by cancer. The purpose of the agency is to lessen the impacts of cancer, address inequalities within cancer treatments, and the improvement of health outcomes in those with cancer. The functions of Cancer Australia are as follows: To offer national leadership regarding the control of cancer To manage the budget for research into cancer To make recommendations to the Australian Government about cancer policy and priorities To mentor scientific research to the prevention of cancer, care, and treatment, and to offer financial assistance for research To offer recommendations regarding the management of cancer to the Australian government and to offer assistance with the implementation of policy To liaise between the shareholders with an interest in the agency To organise and perform any function directed by the Minister
What industry does Cancer Australia operate in?
Cancer Australia, trading as Cancer Australia, is a Private Company that generates the majority of its income from the Health Services industry in Australia.
Where is Cancer Australia located?
Murray Cod Australia Limited company is based at 300 Elizabeth Street, Surry hills, New South Wales, Australia.
Who is the CEO of Cancer Australia?
The Chief Executive Officer of Cancer Australia is Chris Milross and the Chief Executive Officer is Dorothy Keefe.
What was Cancer Australia’s revenue in 2025?
In 2025, Cancer Australia generated total revenue of approximately $13.5 million.
Cut through the noise with intelligence you can trust
